BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 2462502)

  • 1. Decreased TcR-CD3+ T cell numbers in healthy aged humans. Evidence that T cell defects are masked by a reciprocal increase of TcR-CD3- CD2+ natural killer cells.
    Alés-Martínez JE; Alvarez-Mon M; Merino F; Bonilla F; Martínez C; Durántez A; De la Hera A
    Eur J Immunol; 1988 Nov; 18(11):1827-30. PubMed ID: 2462502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
    Scott CF; Bolender S; McIntyre GD; Holldack J; Lambert JM; Venkatesh YP; Morimoto C; Ritz J; Schlossman SF
    J Immunol; 1989 Jun; 142(11):4105-12. PubMed ID: 2565930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
    Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
    J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a CD2- CD3+ T cell receptor-gamma+ peripheral blood lymphocyte subpopulation.
    Faure F; Jitsukawa S; Meuer S; Bohuon C; Triebel F; Hercend T
    J Immunol; 1988 Apr; 140(7):2128-32. PubMed ID: 2895149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S; Boumsell L; Dausset J; Degos L; Bernard A
    Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and natural killer cells.
    Samstag Y; Bader A; Meuer SC
    J Immunol; 1991 Aug; 147(3):788-94. PubMed ID: 1677669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex.
    Anderson P; Caligiuri M; Ritz J; Schlossman SF
    Nature; 1989 Sep; 341(6238):159-62. PubMed ID: 2528695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only.
    Goedegebuure PS; Segal DM; Braakman E; Vreugdenhil RJ; Van Krimpen BA; Van de Griend RJ; Bolhuis RL
    J Immunol; 1989 Mar; 142(6):1797-802. PubMed ID: 2466076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression.
    Hafler DA; Chofflon M; Benjamin D; Dang NH; Breitmeyer J
    J Immunol; 1989 Apr; 142(8):2590-6. PubMed ID: 2564857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
    Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD2 and CD3 antigens mobilize Ca2+ independently.
    O'Flynn K; Knott LJ; Russul-Saib M; Abdul-Gaffar R; Morgan G; Beverley PC; Linch DC
    Eur J Immunol; 1986 May; 16(5):580-4. PubMed ID: 3084290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
    J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
    Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
    J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.
    Van Seventer GA; Van Lier RA; Kuijpers KC; Spits H; Melief CJ
    Eur J Immunol; 1988 Dec; 18(12):1973-8. PubMed ID: 2905994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
    Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD2 can mediate TCR/CD3-independent T cell activation.
    Ohno H; Ushiyama C; Taniguchi M; Germain RN; Saito T
    J Immunol; 1991 Jun; 146(11):3742-6. PubMed ID: 1674520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
    Starling GC; Davidson SE; Nimmo JC; Beard ME; Hart DN
    Clin Exp Immunol; 1989 Dec; 78(3):396-401. PubMed ID: 2532991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.